176 related articles for article (PubMed ID: 36204311)
1. The expression and methylation of
Zhao Y; Zhao J; Zhong M; Zhang Q; Yan F; Feng Y; Guo Y
Front Genet; 2022; 13():982241. PubMed ID: 36204311
[No Abstract] [Full Text] [Related]
2. Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma.
Hu R; Lu M; She L
Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4239-4253. PubMed ID: 37204444
[TBL] [Abstract][Full Text] [Related]
3. Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation.
Feng Y; Zhou YH; Zhao J; Su XL; Chen NX; Zhao YQ; Ye Q; Hu J; Ou-Yang ZY; Zhong MM; Yang YF; Han PJ; Guo Y; Feng YZ
Front Genet; 2023; 14():1041042. PubMed ID: 36936420
[No Abstract] [Full Text] [Related]
4. Spermine synthase (
Pan X; Xue L; Sun Y
Ann Transl Med; 2022 Nov; 10(22):1213. PubMed ID: 36544695
[TBL] [Abstract][Full Text] [Related]
5. Interferon Regulatory Factor Family Genes: At the Crossroads between Immunity and Head and Neck Squamous Carcinoma.
Liu S; Wang Z
Dis Markers; 2022; 2022():2561673. PubMed ID: 35664436
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of CD247 in patients with head and neck squamous cell carcinoma: bioinformatic analysis of TCGA database.
Lin P; Hu XL; Hu YY; Liu MY; Wang QY; Ding Y; Ye JC
Ann Transl Med; 2022 Sep; 10(17):923. PubMed ID: 36172089
[TBL] [Abstract][Full Text] [Related]
7. TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma.
Gao W; Zhang ZW; Wang HY; Li XD; Peng WT; Guan HY; Liao YX; Liu A
Front Genet; 2022; 13():895281. PubMed ID: 35754792
[No Abstract] [Full Text] [Related]
8. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study.
Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M
Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571
[TBL] [Abstract][Full Text] [Related]
9. High PITX1 expression in lung adenocarcinoma patients is associated with DNA methylation and poor prognosis.
Song X; Zhao C; Jiang L; Lin S; Bi J; Wei Q; Yu L; Zhao L; Wei M
Pathol Res Pract; 2018 Dec; 214(12):2046-2053. PubMed ID: 30322808
[TBL] [Abstract][Full Text] [Related]
10. Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma.
Cui K; Yao X; Wei Z; Yang Y; Liu X; Huang Z; Huo H; Tang J; Xie Y
Front Genet; 2022; 13():917344. PubMed ID: 36186458
[No Abstract] [Full Text] [Related]
11. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
12. CCR4 is a prognostic biomarker and correlated with immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Chen K; Li L; Mao W; Shen D; Yao N; Zhang L
Ann Transl Med; 2021 Sep; 9(18):1443. PubMed ID: 34733995
[TBL] [Abstract][Full Text] [Related]
13. Identification of genetic mechanisms underlying lipid metabolism-mediated tumor immunity in head and neck squamous cell carcinoma.
Liu S; Wang S; Wang Z
BMC Med Genomics; 2023 May; 16(1):110. PubMed ID: 37210507
[TBL] [Abstract][Full Text] [Related]
14. The PITX gene family as potential biomarkers and therapeutic targets in lung adenocarcinoma.
Zhang C; Chen X; Chen Y; Cao M; Tang J; Zhong B; He M
Medicine (Baltimore); 2021 Jan; 100(4):e23936. PubMed ID: 33530195
[TBL] [Abstract][Full Text] [Related]
15. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes.
Liu Y; Liu N; Zhou X; Zhao L; Wei W; Hu J; Luo Z
Front Endocrinol (Lausanne); 2023; 14():1245629. PubMed ID: 37876534
[TBL] [Abstract][Full Text] [Related]
16. LINC01614 is a promising diagnostic and prognostic marker in HNSC linked to the tumor microenvironment and oncogenic function.
Tian X; Hu D; Wang N; Zhang L; Wang X
Front Genet; 2024; 15():1337525. PubMed ID: 38655053
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis reveals novel gene signature in head and neck squamous cell carcinoma: predicting is associated with poor prognosis in patients.
Sun Y; Zhang Q; Yao L; Wang S; Zhang Z
Transl Cancer Res; 2020 Oct; 9(10):5882-5892. PubMed ID: 35117201
[TBL] [Abstract][Full Text] [Related]
18. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.
Chen Y
Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491
[TBL] [Abstract][Full Text] [Related]
19. Identification of NUTF2 as a Candidate Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
Zhang R; Gao Y
Onco Targets Ther; 2021; 14():5455-5467. PubMed ID: 35221694
[TBL] [Abstract][Full Text] [Related]
20. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
